Main > VETERINARY MEDICINE > Cats/Felines > Chlamydia psittaci Infection > Vaccine

Product USA. A

PATENT ASSIGNEE'S COUNTRY USA
UPDATE 12.99
PATENT ASSIGNEE This data is not available for free
PATENT CLAIMS A vaccine compn against feline "Chlamydia psittaci" infections comprising an immunogenically active comp consisting of inactivated feline Chlamydia psittaci (I) in a pre-
inactivation titer of > 10 (to fifth power) ELD/50 per dose, an adjuvant, & carrier, wherein said compn is purified of toxic immunogenic egg yolk sac substances, said compn prepd by the process
- Culturing feline (I) in egg yolk sac
- Subculturing said egg yolk sac culture contg the feline (I)
in suitable cell line to remove toxic immunogenic substance
present in egg yolk sac culture
- Harvesting the feline (I) from the contents of the subculture
said contents selected from infected cell line cells
- Inactivating the feline (I) with inactivating agents
- Mixing inactivated feline (I) with adjuvant
PATENT PHOTOCOPY Available on request

Want more information ?
Interested in the hidden information ?
Click here and do your request.


back